We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
-6.3%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$563M
AUM Growth
-$77.2M
Cap. Flow
+$3.41M
Cap. Flow %
0.61%
Top 10 Hldgs %
62.51%
Holding
124
New
20
Increased
17
Reduced
10
Closed
12

Top Buys

1
GPGI
GPGI Inc
GPGI
+$11M
2
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$10.8M
3
BC icon
Brunswick
BC
+$5.76M
4
TV icon
Televisa
TV
+$5.18M
5
DUOT icon
Duos Technologies
DUOT
+$4.54M

Top Sells

1
RPRX icon
Royalty Pharma
RPRX
+$32.8M
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$3.66M
3
IHC
Independence Holding Company
IHC
+$3.1M
4
EPD icon
Enterprise Products Partners
EPD
+$2.77M
5
TLMD
SOC Telemed, Inc. Class A Common Stock
TLMD
+$2.76M

Sector Composition

1 Healthcare 17.55%
2 Industrials 15.14%
3 Financials 14.94%
4 Materials 10.92%
5 Consumer Discretionary 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LGF.B
76
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$247K 0.04%
16,413
– –
OTIS icon
77
Otis Worldwide
OTIS
$28.1B
$231K 0.04%
3,000
– –
PHYS icon
78
Sprott Physical Gold
PHYS
$14.4B
$193K 0.03%
12,540
– –
FLNA
79
Filana Therapeutics
FLNA
$51.2M
$186K 0.03%
5,000
-7,500
-60% -$318K
CORS.WS
80
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$175K 0.03%
416,666
– –
EQRXW
81
DELISTED
EQRx, Inc. Warrant
EQRXW
$165K 0.03%
200,000
– –
LILAK icon
82
Liberty Latin America Class C
LILAK
$1.47B
$158K 0.03%
18,174
– –
CMPOW
83
DELISTED
CompoSecure Inc Warrant
CMPOW
$155K 0.03%
+100,000
New +$140K
PACXW
84
DELISTED
Pioneer Merger Corp. Warrant
PACXW
$143K 0.03%
708,333
– –
OPFI.WS icon
85
OppFi Inc Warrants
OPFI.WS
$129K 0.02%
250,000
– –
AMD icon
86
Advanced Micro Devices
AMD
$815B
$100K 0.02%
+913
New +$109K
BNY
87
Bank of New York Mellon
BNY
$108B
$99K 0.02%
2,000
– –
XOM icon
88
ExxonMobil
XOM
$612B
$89K 0.02%
1,075
– –
CDNS icon
89
Cadence Design Systems
CDNS
$90.6B
$86K 0.02%
525
– –
ABBV icon
90
AbbVie
ABBV
$452B
$83K 0.01%
515
– –
ISLEW
91
DELISTED
Isleworth Healthcare Acquisition Corporation Warrant
ISLEW
$83K 0.01%
500,000
– –
TER icon
92
Teradyne
TER
$50.9B
$71K 0.01%
600
– –
FAZEW
93
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$68K 0.01%
75,000
– –
AENTW icon
94
Alliance Entertainment Holding Corp Warrants
AENTW
$3.77M
$64K 0.01%
200,000
– –
LITE icon
95
Lumentum
LITE
$57.4B
$64K 0.01%
660
– –
MO icon
96
Altria Group
MO
$123B
$63K 0.01%
1,200
– –
XFOR icon
97
X4 Pharmaceuticals
XFOR
$356M
$63K 0.01%
1,191
– –
LILA icon
98
Liberty Latin America Class A
LILA
$1.47B
$39K 0.01%
5,913
– –
T icon
99
AT&T
T
$151B
$39K 0.01%
2,185
– –
BRIVW
100
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$38K 0.01%
75,000
– –
1 2 3
4
5

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q1 2022 Portfolio in Review

As of Q1 2022, Bleichroeder LP held 124 positions worth $563M, down 12% from $641M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bleichroeder LP's Q1 2022 filing shows 20 new, 17 increased, 10 reduced and 12 closed positions. Its largest new stake was GPGI Inc: 1,776,008 shares worth $11.2M. The largest sale was Royalty Pharma, an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 24% a quarter earlier, followed by Industrials and Financials.

  • Bleichroeder LP's largest Q1 2022 buy was GPGI Inc: 1,776,008 shares worth $11.2M.
  • Bleichroeder LP added most to CTI BioPharma Corp. (DE) Common Stock in Q1 2022, an estimated $10.8M increase.
  • Bleichroeder LP's biggest Q1 2022 reduction was Tricida, Inc. Common Stock, cutting an estimated $1.53M.
  • Bleichroeder LP fully exited Royalty Pharma in Q1 2022, selling an estimated $32.8M.
  • Bleichroeder LP's ten largest holdings make up 63% of its $563M portfolio in Q1 2022.
  • Bleichroeder LP opened 20 new positions and closed 12 in Q1 2022.
  • Bleichroeder LP's portfolio value fell 12% quarter-over-quarter to $563M.

Based on Bleichroeder LP's 13F filing for Q1 2022, filed 11 May 2022.